Precision medicine development and validation of a multi-fluorescent automated assay to quantify BCL2 and CCND1 expression in CD138 positive bone marrow multiple myeloma (MM) cells

被引:0
|
作者
Khong, T. [1 ]
Savvidou, I. [1 ]
Hader, C. [1 ]
Spencer, A. [1 ]
机构
[1] Monash Univ, Alfred Hosp, Australian Ctr Blood Dis, Myeloma Res Grp, Melbourne, Vic, Australia
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
PS-10-005
引用
收藏
页码:S115 / S115
页数:1
相关论文
共 1 条
  • [1] Overexpression of cyclin D1 (CCND1) is associated with lower percentage of CD38(-) bone marrow (BM) cells in-S-phase in multiple myeloma (MM) patients:: A putative anti-proliferative effect.
    Macro, M
    Salaun, V
    Chèze, S
    Sola, B
    Roussel, M
    Reman, O
    Leporrier, M
    Henry-Amar, M
    Troussard, X
    BLOOD, 2002, 100 (11) : 369B - 369B